ArticleJournal of nanobiotechnology2025
Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.
Jingru Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.